Huge decision: FDA won’t restrict CBD sales, calls for ‘new regulatory pathway’ to assure safety

On: January 26, 2023

FDA officials found that CBD doesn’t fit existing regulations. They want Congress to create new rules, and will allow the exiting market to continue.

The post Huge decision: FDA won’t restrict CBD sales, calls for ‘new regulatory pathway’ to assure safety appeared first on Leafly.

Read More: Huge decision: FDA won’t restrict CBD sales, calls for ‘new regulatory pathway’ to assure safety

Previous Post: FDA Announces It Will Not Issue Rules To Allow CBD As Dietary Supplements Or Food Items, Punting To Congress For Regulations

Next Post: Marijuana Legalization Not Associated With Increased Rates Of Psychosis, American Medical Association Study Of 63 Million People Finds

Comments are closed, but trackbacks and pingbacks are open.